Trial · NCT04605094
Adverse events33
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 33
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Bronchitis | Infections and infestations | Benralizumab | 5 | 96 | 5 |
| other | Bronchitis | Infections and infestations | Placebo | 0 | 98 | 0 |
| other | Bronchitis | Infections and infestations | Placebo to Benralizumab | 4 | 87 | 4 |
| other | Conjunctivitis | Infections and infestations | Benralizumab | 3 | 96 | 4 |
| other | Conjunctivitis | Infections and infestations | Placebo | 0 | 98 | 0 |
| other | Conjunctivitis | Infections and infestations | Placebo to Benralizumab | 6 | 87 | 6 |
| other | COVID-19 | Infections and infestations | Benralizumab | 21 | 96 | 23 |
| other | COVID-19 | Infections and infestations | Placebo | 4 | 98 | 4 |
| other | COVID-19 | Infections and infestations | Placebo to Benralizumab | 14 | 87 | 14 |
| other | Nasopharyngitis | Infections and infestations | Benralizumab | 9 | 96 | 10 |
| other | Nasopharyngitis | Infections and infestations | Placebo | 0 | 98 | 0 |
| other | Nasopharyngitis | Infections and infestations | Placebo to Benralizumab | 7 | 87 | 8 |
| other | Upper respiratory tract infection | Infections and infestations | Benralizumab | 9 | 96 | 12 |
| other | Upper respiratory tract infection | Infections and infestations | Placebo | 2 | 98 | 3 |
| other | Upper respiratory tract infection | Infections and infestations | Placebo to Benralizumab | 5 | 87 | 5 |
| other | Headache | Nervous system disorders | Benralizumab | 4 | 96 | 4 |
| other | Headache | Nervous system disorders | Placebo | 5 | 98 | 8 |
| other | Headache | Nervous system disorders | Placebo to Benralizumab | 0 | 87 | 0 |
| serious | Cardiac failure congestive | Cardiac disorders | Benralizumab | 1 | 96 | 1 |
| serious | Cardiac failure congestive | Cardiac disorders | Placebo | 0 | 98 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04605094/events